WANG YuanSenior Partner
Mr. WANG has been practicing law since 2002. In his many years of practice, he has advised on fund formation and investment, asset restructuring, M&A, IPOs and refinancing. He is an expert on fund formation, PE, FDI, asset restructuring, M&A, IPO, refinancing. He has expertise in the medical, auto, entertainment, environmental, manufacturing, FMGG and agriculture industries. Mr. Wang has assisted in providing professional services to multi-national corporations on various matters of corporate restructuring, mergers and acquisitions, establishing foreign-invested enterprises, etc.. Mr. Wang has represented many multinational companies, private equity funds, public companies and IPO applicants in cross-border mergers and acquisitions, fund formation, restructuring and financing projects. He also advised various domestic private and public companies throughout China in respect of restructuring planning, due diligence, documentation and execution.
Representative Deals
- Mr. Wang has led and participated in numerous non-litigation deals including: SEQUOIA Capital’s equity investments in Betta Pharmaceuticals, CSD Water Service, Angel Group, Hero Entertainment, CardInfoLink and more, Qiming Venture’s equity investments in Hexing Electrical, APT Medical, Rendu Biotechnology, P&P Biotech and more; E Fund Management’s equity investment in Ant Financial, CITIC’s Goldstone’s establishment of a special fund to participate in the Sinopec Chemical Commercial Holding investment, GP Capital’s equity investment in Ganghai (Tianjin) Construction, Pingan Venture’s equity investment and capital investment in Jiangxi Jinyuan, CITIC Agriculture’s establishment of Agricultural Industry Fund, Haitong Capital Investment’s establishment of Xi’an Aerospace’s New Energy Funds, Shanghai Cultural Industry Funds, Hefei New Industry Funds, and many other fund establishment projects; Spring Airlines’ IPO of A-shares, main board listing and issuance of corporate bonds, Tigermed’s IPO of A-shares and main board listing, SAIC Motor’s IPO and non-public offering, Huayu Auto’s issuance of corporate bonds and non-public offering, Black Peony Group’s issuance of corporate bonds and non-public offering, China United Travel’s non-public offering, Shanghai Hooyi Displays & Fixtures Industries’ NEEQ listing, Daning Group’s issuance of commercial paper, and many other capital market projects; SAIC Motor and Huayu Auto's establishment of a joint venture in Thailand, Tigermed's acquisition of Frontage Laboratories and BDM in the U.S., and many other FDI projects . Furthermore, Mr. Wang provides perennial legal services to Haitong Capital Investment, Shanghai Anjie Capital, Spring Airlines, Tigermed, China United Travel, Black Peony Group and many other private equity funds and listed companies.
Education
- 1999, LLB, Peking University
- 2002, LLM, Peking University
- 2008, LLM, Columbia University
Bar Admission
- 1999, PRC
- 2009, New York, U.S.A
Academic paper
- “Shareholder’s Derivative Action - A study in depth based on a classical case”, in Private Law N.2, Volume II
- “Duty of Disclosure of Insured in Marine Insurance Contract---Study on Article 222 and 223 in Maritime Law”, in Fudan Law Review on Civil and Commercial law, May 2003
- “The Right to Silence and the obligation of Truthful Statement—Who is using violence? “，in Journal of Comparative Law, N. 1, 2002
- “The Status and other relevant issues of Shareholder of Limited Liability Company”, in Juristic Case, N. 4, 2002
